UnitedHealth, Amgen Share Gains Lead Dow's 114-Point Climb

Dow Jones11-21 04:35

DJ UnitedHealth, Amgen Share Gains Lead Dow's 114-Point Climb

This article was automatically generated by MarketWatch using technology from Automated Insights.

Behind positive gains for shares of UnitedHealth and Amgen, the Dow Jones Industrial Average is climbing Wednesday afternoon.

The Dow (Dow Jones Industrial Average) was most recently trading 114 points (0.3%) higher, as shares of UnitedHealth (UnitedHealth Group Inc.) and Amgen (Amgen Inc.) have contributed to the blue-chip gauge's intraday rally.

UnitedHealth's shares are up $22.08 (3.8%) while those of Amgen have risen $7.41 (2.7%), combining for a roughly 181-point bump for the Dow.

IBM (International Business Machines Corp.), Walt Disney (Walt Disney Co.), and Merck (Merck & Co. Inc.) are also contributing significantly to the gain.

A $1 move in any one of the 30 components of the benchmark results in a 6.15-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled November 20, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

November 20, 2024 15:35 ET (20:35 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment